Combined inhibition of PLK4 and PPM1D promotes cell death in cancer cells with 17q amplification

Miroslav Stoyanov, Cecilia Aquino-Perez, Shreyasi Mazumder, Dominika Salcakova, Silvia Petrezselyova, Libor Macurek · 2026

Read Combined inhibition of PLK4 and PPM1D promotes cell death in cancer cells with 17q amplification by Miroslav Stoyanov, Cecilia Aquino-Perez, Shreyasi Mazumder, Dominika Salcakova, Silvia Petrezselyova, Libor Macurek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13523465.txt.

Description

Miroslav Stoyanov and colleagues report 2026 laboratory work on drug combinations for cancers carrying extra copies of a section of chromosome 17 known as 17q. PLK4, a protein that controls centriole copying during cell division, is already a drug target in some breast cancers and neuroblastomas with this gain. The team searched for factors that limit how well PLK4 blockade works.

Using cancer genomics portals, the group identified PPM1D, a phosphatase that restrains the tumor suppressor p53, as a key limiter. Blocking PLK4 and PPM1D together switched on p53 target genes and drove cell death in breast cancer cells with 17q gains. Pairing PLK4 blockade with MDM2 blockade had a similar lethal effect, while removing p53 protected cells. Results in two neuroblastoma lines supported the same strategy.

Catalog record

CREATORMiroslav Stoyanov, Cecilia Aquino-Perez, Shreyasi Mazumder, Dominika Salcakova, Silvia Petrezselyova, Libor Macurek
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36040
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13523465

Browse the full library · About the Tower of Babel